Charles Schwab
TVTY

Charles Schwab’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Charles Schwab’s Portfolio TVTY Stock Details TVTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-344,252
Closed -$11.1M – 3710
2022
Q1 		$11.1M Buy
344,252
+32,309
+10% +$874K ﹤0.01% 1898
2021
Q4 		$8.25M Buy
311,943
+4,233
+1% +$108K ﹤0.01% 2100
2021
Q3 		$7.1M Buy
307,710
+33,116
+12% +$786K ﹤0.01% 2207
2021
Q2 		$7.22M Sell
274,594
-26,785
-9% -$673K ﹤0.01% 2169
2021
Q1 		$6.73M Sell
301,379
-194,159
-39% -$4.45M ﹤0.01% 2154
2020
Q4 		$9.71M Sell
495,538
-12,782
-3% -$212K ﹤0.01% 1884
2020
Q3 		$7.13M Sell
508,320
-18,596
-4% -$268K ﹤0.01% 1891
2020
Q2 		$5.97M Sell
526,916
-60,587
-10% -$554K ﹤0.01% 1943
2020
Q1 		$3.7M Buy
587,503
+68,877
+13% +$1.11M ﹤0.01% 1981
2019
Q4 		$10.6M Buy
518,626
+57,746
+13% +$1.08M 0.01% 1648
2019
Q3 		$7.67M Buy
460,880
+53,167
+13% +$920K ﹤0.01% 1758
2019
Q2 		$6.7M Buy
407,713
+48,866
+14% +$943K ﹤0.01% 1832
2019
Q1 		$6.3M Buy
358,847
+94,017
+36% +$2M ﹤0.01% 1863
2018
Q4 		$6.57M Buy
264,830
+15,234
+6% +$506K 0.01% 1730
2018
Q3 		$8.03M Buy
249,596
+43,751
+21% +$1.49M 0.01% 1778
2018
Q2 		$7.25M Buy
205,845
+23,143
+13% +$854K 0.01% 1803
2018
Q1 		$7.25M Sell
182,702
-18,169
-9% -$705K 0.01% 1725
2017
Q4 		$7.34M Buy
200,871
+43,099
+27% +$1.63M 0.01% 1687
2017
Q3 		$6.44M Buy
157,772
+8,130
+5% +$315K 0.01% 1740
2017
Q2 		$5.96M Buy
149,642
+6,285
+4% +$210K 0.01% 1703
2017
Q1 		$4.17M Buy
143,357
+8,007
+6% +$211K ﹤0.01% 1861
2016
Q4 		$3.08M Buy
135,350
+16,002
+13% +$376K ﹤0.01% 1984
2016
Q3 		$3.16M Buy
119,348
+18,609
+18% +$376K ﹤0.01% 1908
2016
Q2 		$1.16M Buy
100,739
+1,428
+1% +$16.7K ﹤0.01% 2300
2016
Q1 		$1M Buy
99,311
+1,734
+2% +$19.5K ﹤0.01% 2349
2015
Q4 		$1.26M Sell
97,577
-26,481
-21% -$322K ﹤0.01% 2291
2015
Q3 		$1.38M Buy
124,058
+27,643
+29% +$338K ﹤0.01% 2257
2015
Q2 		$1.16M Sell
96,415
-52,243
-35% -$867K ﹤0.01% 2360
2015
Q1 		$2.93M Buy
148,658
+10,708
+8% +$224K ﹤0.01% 1850
2014
Q4 		$2.74M Sell
137,950
-3,441
-2% -$56.2K ﹤0.01% 1830
2014
Q3 		$2.27M Buy
141,391
+2,445
+2% +$41.5K ﹤0.01% 1897
2014
Q2 		$2.44M Buy
138,946
+659
+0.5% +$11.3K ﹤0.01% 1880
2014
Q1 		$2.37M Buy
138,287
+14,745
+12% +$227K ﹤0.01% 1855
2013
Q4 		$1.9M Buy
123,542
+3,690
+3% +$52.4K ﹤0.01% 1953
2013
Q3 		$2.24M Buy
119,852
+2,154
+2% +$38.9K ﹤0.01% 1778
2013
Q2 		$1.91M Buy
+117,698
New +$1.62M ﹤0.01% 1788

Other funds holding TVTY

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
PP
Pacifica Partners Surrey, Canada $332M AUM 43.09% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Charles Schwab's TVTY Position: Q2 2022 in Review

Charles Schwab sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 344,252 shares — an estimated $11.1M sold.

Charles Schwab first reported a position in TVTY in Q2 2013 and held it in 36 quarters. The position peaked at $11.1M in Q1 2022. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • Charles Schwab reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Charles Schwab sold 344,252 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $11.1M.
  • Charles Schwab first reported a position in Tivity Health, Inc. Common Stock in Q2 2013 and held it in 36 quarters.
  • Charles Schwab's Tivity Health, Inc. Common Stock position peaked at $11.1M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.